Sustaining Blood Lymphocyte Count during Preoperative Chemoradiotherapy as a Predictive Marker for Pathologic Complete Response in Locally Advanced Rectal Cancer
Cancer Research and Treatment. 2016;48(1):232-239 
Nodal tumor response according to the count of peripheral blood lymphocyte subpopulations during preoperative chemoradiotherapy in locally advanced rectal cancer
Radiation Oncology Journal. 2016;34(4):305-312
EP-1255: Predictive factors for pathologic complete response after preoperative chemoradiotherapy in rectal cancer
Radiotherapy and Oncology. 2014;111:S74
Comments on “High lymphocyte count during neoadjuvant chemoradiotherapy is associated with improved pathologic complete response in esophageal cancer”
Radiotherapy and Oncology. 2019;131:239
Pathologic Complete Response of Primary Tumor Following Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer: Long-term Outcomes and Prognostic Significance of Pathologic Nodal Status (KROG 09-01)
Yearbook of Surgery. 2012;2012:274-276
How to Achieve a Higher Pathologic Complete Response in Patients With Locally Advanced Rectal Cancer Who Receive Preoperative Chemoradiation Therapy
Annals of Coloproctology. 2019;35(1):3-8
P-022 Predictive biomarkers of pathologic response to preoperative chemoradiotherapy in locally advanced rectal cancer
Annals of Oncology. 2016;27:ii7
Clinical predictive factors of pathologic tumor response after preoperative chemoradiotherapy in rectal cancer
Radiation Oncology Journal. 2012;30(3):99
Complete pathologic response after preoperative rectal cancer chemoradiotherapy
ANZ Journal of Surgery. 2009;79(6):481-484
Predictive value of repeated F-18 FDG PET/CT parameters changes during preoperative chemoradiotherapy to predict pathologic response and overall survival in locally advanced esophageal adenocarcinoma patients
Cancer Chemotherapy and Pharmacology. 2016;77(4):723-731